Boutsen Y - Search Results

1

Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity.

Manicourt DH, Brasseur JP, Boutsen Y, Depreseux G, Devogelaer JP. Manicourt DH, et al. Among authors: boutsen y. Arthritis Rheum. 2004 Nov;50(11):3690-7. doi: 10.1002/art.20591. Arthritis Rheum. 2004. PMID: 15529370 Free article. Clinical Trial.

2

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.

Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP. Boutsen Y, et al. J Bone Miner Res. 2001 Jan;16(1):104-12. doi: 10.1359/jbmr.2001.16.1.104. J Bone Miner Res. 2001. PMID: 11149473 Free article. Clinical Trial.

3

Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.

Devogelaer JP, Goemaere S, Boonen S, Body JJ, Kaufman JM, Reginster JY, Rozenberg S, Boutsen Y. Devogelaer JP, et al. Among authors: boutsen y. Osteoporos Int. 2006 Jan;17(1):8-19. doi: 10.1007/s00198-005-2032-z. Epub 2005 Oct 11. Osteoporos Int. 2006. PMID: 16217586

4

Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.

Devogelaer JP, Boutsen Y, Manicourt DH. Devogelaer JP, et al. Among authors: boutsen y. Curr Osteoporos Rep. 2010 Sep;8(3):154-61. doi: 10.1007/s11914-010-0024-1. Curr Osteoporos Rep. 2010. PMID: 20563900

5

Is there a place for bone turnover markers in the assessment of osteoporosis and its treatment?

Devogelaer JP, Boutsen Y, Gruson D, Manicourt D. Devogelaer JP, et al. Among authors: boutsen y. Rheum Dis Clin North Am. 2011 Aug;37(3):365-86, v-vi. doi: 10.1016/j.rdc.2011.07.002. Rheum Dis Clin North Am. 2011. PMID: 22023897 Review.

6

Antacid-induced osteomalacia.

Boutsen Y, Devogelaer JP, Malghem J, Noel H, Nagant de Deuxchaisnes C. Boutsen Y, et al. Clin Rheumatol. 1996 Jan;15(1):75-80. doi: 10.1007/BF02231691. Clin Rheumatol. 1996. PMID: 8929782 Review.

7

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis.

Delabaye I, De Keyser F; REMITRACT study group. Delabaye I, et al. Arthritis Res Ther. 2010;12(3):R121. doi: 10.1186/ar3058. Epub 2010 Jun 22. Arthritis Res Ther. 2010. PMID: 20569501 Free PMC article.

8

Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial.

Boutsen Y, Jamart J, Esselinckx W, Stoffel M, Devogelaer JP. Boutsen Y, et al. Calcif Tissue Int. 1997 Oct;61(4):266-71. doi: 10.1007/s002239900334. Calcif Tissue Int. 1997. PMID: 9312195 Clinical Trial.

9

[Evaluation of corticosteroid replacement therapy and its effect on bones in Addison's disease].

Heureux F, Maiter D, Boutsen Y, Devogelaer JP, Jamart J, Donckier J. Heureux F, et al. Among authors: boutsen y. Ann Endocrinol (Paris). 2000 Sep;61(3):179-83. Ann Endocrinol (Paris). 2000. PMID: 10970940 French.

10

Management of cancer treatment-induced bone loss in early breast and prostate cancer -- a consensus paper of the Belgian Bone Club.

Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Reginster JY, Rozenberg S, Kaufman JM. Body JJ, et al. Among authors: boutsen y. Osteoporos Int. 2007 Nov;18(11):1439-50. doi: 10.1007/s00198-007-0439-4. Epub 2007 Aug 10. Osteoporos Int. 2007. PMID: 17690930 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters